Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials

BACKGROUND: We conducted a systematic review and meta-analysis to clarify the risk of early and late cardiotoxicity of anthracycline agents in patients treated for breast or ovarian cancer, lymphoma, myeloma or sarcoma. METHODS: Randomized controlled trials were sought using comprehensive searches o...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Lesley A, Cornelius, Victoria R, Plummer, Christopher J, Levitt, Gill, Verrill, Mark, Canney, Peter, Jones, Alison
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907344/
https://www.ncbi.nlm.nih.gov/pubmed/20587042
http://dx.doi.org/10.1186/1471-2407-10-337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907344/
https://www.ncbi.nlm.nih.gov/pubmed/20587042
http://dx.doi.org/10.1186/1471-2407-10-337

Ejemplares similares